Novartis licences drugs to non-profit TB group

Swiss-based pharmaceuticals giant Novartis said Wednesday that it had signed a licensing deal with an international organisation that fights tuberculosis.

In a statement, the group said that the exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development covered compounds discovered at the Novartis Institutes for Tropical Diseases.

All told, TB claimed 1.3 million lives worldwide last year, making it the deadliest disease after AIDS to be caused by a single infectious agent, according to the World Health Organization.

WHO figures show that there are 8.6 million cases of TB every year, and that drug-resistant forms are a huge emerging threat.

The disease is global, but its hotspots include China, India and the former communist countries of eastern Europe and central Asia.

The WHO last month called for a massive new international effort to try to wipe out TB by 2050.

Under the terms of agreement, Novartis will fully transfer its TB research and development programme to the Global Alliance.

The latter will take financial and operational responsibility for continued research, development, approval and distribution of compounds in the portfolio, Novartis said.

Pharmaceuticals in the deal include a novel class of drugs called indolcarboxamides that are active against drug sensitive and multi-resistant strains of TB.

add to favorites email to friend print save as pdf

Related Stories

India must stop 'irrational' TB treatments: MSF

Mar 23, 2014

India must stop its doctors prescribing "irrational" treatments to cure tuberculosis, medical humanitarian group Medecins Sans Frontieres said Saturday, warning the practice is increasing drug-resistant strains of the disease.

New drug regimen speeds TB treatment

Jul 21, 2014

An experimental cocktail of three drugs can dramatically shorten the time it takes to treat patients infected with TB strains that are hard to cure with conventional antibiotics, according to research presented ...

Recommended for you

Sierra Leone streets deserted as shutdown begins

50 minutes ago

Sierra Leone's normally chaotic capital was transformed on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

2 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

Cooling of dialysis fluids protects against brain damage

15 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

15 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments